Gene · 5905
Papers1,466
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,466
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hepatitis B virus X protein increases LASP1 SUMOylation to stabilize HER2 and facilitate hepatocarcinogenesis. | Int J Biol Macromol | 2023 | 36473530 | PubTator, text mining | PubMed |
| Research progress on the circRNA‑mediated regulation of tumor angiogenesis through ceRNA mechanisms (Review). | Oncol Rep | 2023 | 36416347 | PubTator, text mining | PubMed |
| In-Plate Chemical Synthesis of Isopeptide-Linked SUMOylated Peptide Fluorescence Polarization Reagents for High-Throughput Screening of SENP Preferences. | Chembiochem | 2023 | 36377600 | PubTator, text mining | PubMed |
| RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | J Cell Biol | 2023 | 36282215 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| Non-coding RNA regulatory networks in post-transcriptional regulation of VEGFA in cancer. | IUBMB Life | 2023 | 35467790 | PubTator, text mining | PubMed |
| Exosomes and cancer immunotherapy: A review of recent cancer research. | Front Oncol | 2022 | 36727049 | PubTator, text mining | PubMed |
| Systematic Insight of Resveratrol Activated SIRT1 Interactome through Proximity Labeling Strategy. | Antioxidants (Basel) | 2022 | 36552538 | PubTator, text mining | PubMed |
| SUMO monoclonal antibodies vary in sensitivity, specificity, and ability to detect types of SUMO conjugate. | Sci Rep | 2022 | 36494414 | PubTator, text mining | PubMed |
| NUSAP1 and PCLAF (KIA0101) Downregulation by Neoadjuvant Therapy is Associated with Better Therapeutic Outcomes and Survival in Breast Cancer. | J Oncol | 2022 | 36478748 | PubTator, text mining | PubMed |
| Circular RNA hsa_circ_0007990 as a blood biomarker for unruptured intracranial aneurysm with aneurysm wall enhancement. | Front Immunol | 2022 | 36466848 | PubTator, text mining | PubMed |
| Extracellular RNA as a kind of communication molecule and emerging cancer biomarker. | Front Oncol | 2022 | 36465402 | PubTator, text mining | PubMed |
| Non-transport roles of nuclear import receptors: In need of the right balance. | Front Cell Dev Biol | 2022 | 36438555 | PubTator, text mining | PubMed |
BDE-47, -99, -209 and Their Ternary Mixture Disrupt Glucose and Lipid Metabolism of Hepg2 Cells at Dietary Relevant Concentrations: Mechanistic Insight through Integrated Transcriptomics and Proteomics Analysis. | Int J Mol Sci | 2022 | 36430946 | PubTator, text mining | PubMed |
| Identification of Factors Driving Doxorubicin-Resistant Ewing Tumor Cells to Survival. | Cancers (Basel) | 2022 | 36428591 | PubTator, text mining | PubMed |
| Hsa_circ_0074158 regulates the endothelial barrier function in sepsis and its potential value as a biomarker. | Front Genet | 2022 | 36425075 | PubTator, text mining | PubMed |
| Tough Way In, Tough Way Out: The Complex Interplay of Host and Viral Factors in Nucleocytoplasmic Trafficking during HIV-1 Infection. | Viruses | 2022 | 36423112 | PubTator, text mining | PubMed |
| Diversity is the spice of life: An overview of how cytokinesis regulation varies with cell type. | Front Cell Dev Biol | 2022 | 36420142 | PubTator, text mining | PubMed |
| A mass spectrometry-based approach for the identification of Kpnβ1 binding partners in cancer cells. | Sci Rep | 2022 | 36418423 | PubTator, text mining | PubMed |
| Cytokinetic diversity in mammalian cells is revealed by the characterization of endogenous anillin, Ect2 and RhoA. | Open Biol | 2022 | 36416720 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5905/papers?page=8